glimepiride has been researched along with Hepatocellular Carcinoma in 2 studies
glimepiride: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JY | 2 |
| Kim, G | 1 |
| Lee, YH | 1 |
| Lee, BW | 1 |
| Cha, BS | 1 |
| Nam, CM | 2 |
| Kang, ES | 2 |
| Jang, SY | 1 |
1 trial available for glimepiride and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Female; Glicla | 2019 |
1 other study available for glimepiride and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide.
Topics: Aged; Carcinoma, Hepatocellular; Female; Gliclazide; Humans; Hypoglycemic Agents; Incidence; Liver N | 2019 |